# Yosemite

> Reed Jobs' San Francisco oncology-focused venture investor, independent since 2023. Invests in cancer medicine, diagnostics and care delivery, and also supports separate nonprofit scientific grants. Fund I closed at $263M in 2024, Fund II reached $350M final close disclosed November 4, 2026.

## Profile

- **Stage-based planning range:** $1M–$10M
- **Check-size evidence basis:** estimated
- **Founded:** 2023
- **Headquarters:** San Francisco, USA
- **AUM:** N/A
- **Rounds they lead:** N/A
- **Rounds they invest:** Seed, Series A, Series B, Growth

## Links

- [Website](https://yosemite.co/)

## Research sources

- [Founder interview, Fortune, Nov 4 2026](https://fortune.com/2026/11/04/reed-jobs-yosemite-raises-350-million-second-fund-make-cancer-non-lethal/)

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/fund/yosemite